Fluvastatin AmelIorates aTHerosclerosis Study
NCT01681199
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Coronary Heart Disease
Atherosclerosis
Interventions
DRUG:
Fluvastatin extended release tablet
Sponsor
Beijing Anzhen Hospital
Collaborators
[object Object]